CHINOOK THERAPEUTICS, INC. (KDNY) has 44 open-market insider trades by 8 insiders since 2020. The most active filer is Eric Dobmeier, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Davis Jerel | Dir | — | 4 | $46.8M | 2023-08-11 |
| Srinivas Akkaraju | Dir | — | 3 | $27.5M | 2023-08-11 |
| Eric Dobmeier | CEOPres | — | 11 | $2.7M | 2023-08-11 |
| Tom Frohlich | COO | — | 9 | $2.0M | 2023-08-11 |
| Andrew James King | CSO | — | 10 | $1.0M | 2023-08-11 |
| Eric Bjerkholt | CFO | — | 4 | $432K | 2023-08-11 |
| Alan Glicklich | — | — | 2 | $357K | 2022-02-11 |
| Dolca Thomas | Dir | — | 1 | $212K | 2023-08-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrew James King | Chief Scientific Officer | Sell | $46K | 2023-08-01 |
| William Mariner Greenman | Director | Sell | $27K | 2023-05-30 |
| Eric Dobmeier | CEO & President | Sell | $1.1M | 2023-04-24 |
| Davis Jerel | Director | Sell | $6.1M | 2023-04-17 |
| Mahesh Krishnan | Director | Sell | $21K | 2023-04-04 |
| Andrew James King | CSO | Sell | $117K |
Companies that share insiders with KDNY, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-04-03 |
| Davis Jerel | Director | Sell | $12.7M | 2023-03-01 |
| Tom Frohlich | COO | Sell | $88K | 2023-02-10 |
| Eric Bjerkholt | CFO | Sell | $20K | 2023-02-10 |
| Andrew James King | CSO | Sell | $57K | 2023-02-10 |
| Eric Dobmeier | CEO & President | Sell | $385K | 2023-02-10 |
| Andrew James King | CSO | Sell | $160K | 2023-01-31 |
| Eric Bjerkholt | CFO | Sell | $143K | 2023-01-31 |
| Tom Frohlich | COO | Sell | $225K | 2023-01-31 |
| Eric Dobmeier | CEO & President | Sell | $993K | 2023-01-30 |